AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / CL A NEW
Total 13F shares
158,861,793
Share change
+42,840,765
Total reported value
$1,892,550,461
Put/Call ratio
16%
Price per share
$11.92
Number of holders
141
Value change
+$535,418,842
Number of buys
94
Number of sells
50

Institutional Holders of AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR) as of Q3 2014

As of 30 Sep 2014, AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR) was held by 141 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 158,861,793 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, FMR LLC, BlackRock Fund Advisors, Jefferies Group LLC, State Street Corp, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., and Miura Global Management, LLC. This page lists 141 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.